Shitanshu Uppal

GOG 92: Sedlis Criteria Study

Adjuvant pelvic radiotherapy significantly reduces the risk of cancer recurrence in women with Stage IB cervical cancer who have undergone radical hysterectomy and pelvic lymphadenectomy and possess specific high-risk factors. The treatment is associated with higher but acceptable morbidity.

SIENDO Trial: Selinexor in TP53wt Advanced or Recurrent Endometrial Cancer

SLND in Cervical Cancer

Landoni Trial: Radical Surgery versus Radiotherapy for Stage Ib-IIa Cervical Cancer

There is no clear treatment of choice for early-stage cervical carcinoma in terms of overall or disease-free survival. Treatment should be tailored to individual patient factors such as menopausal status, age, medical conditions, histological type, and cervical diameter to achieve the best outcomes

Publications Update # 60

PARP inhibitors in ovarian cancer and recent withdrawals, Current FDA indications, Platinum resistant ovarian cancer management, SIENDO trial

Early Stage Cervical Cancer

CONCERV Trial

Conservative surgery is feasible for select patients with early-stage, low-risk cervical cancer

Publication Update # 60 Delayed

SENTIREC: SLND in Cervical Cancer Study from Denmark

SENTICOL 2: Quality of Life After Sentinel Lymph Node Dissection in Cervical Cancer